U.S. Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, CNS Diseases, Others), By End Use (Patients, Providers, Payers, Employers, Others), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology And Scope
                   1.1 Market Segmentation And Scope
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 Gvr’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information Or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                   1.7 List Of Secondary Sources
Chapter 2. Executive Summary
                   2.1 U.S. Digital Therapeutics Market Summary
Chapter 3. U.S. Digital Therapeutics Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent Market Outlook
                       3.1.2 Related/Ancillary Market Outlook
                   3.2. Penetration & Growth Prospect Mapping, 2021
                   3.3 U.S. Digital Therapeutics Market Dynamics
                       3.3.1 Market Driver Analysis
                       3.3.2 Market Restraint Analysis
                       3.3.3. Market Opportunity Analysis
                       3.3.4. Market Challenge Analysis
                   3.4 U.S. Digital Therapeutics Market Analysis Tools: Porter’s Five Forces
                       3.4.1 Supplier Power
                       3.4.2 Buyer Power
                       3.4.3 Substitution Threat
                       3.4.4 Threat Of New Entrants
                       3.4.5 Competitive Rivalry
                   3.5 U.S. Digital Therapeutics Industry Analysis - Pest (Political & Legal, Economic, Social, And Technological)
                       3.5.1 Political/Legal Landscape
                       3.5.2 Economic Landscape
                       3.5.3 Social Landscape
                       3.5.4 Technology Landscape
                   3.6. Regulatory & Reimbursement Scenario
Chapter 4. Covid-19 Impact Analysis
                   4.1 Covid-19 Prevalence Analysis
                   4.2. Current Impact & Future Scenario
                   4.3. Impact On Market Players
Chapter 5. U.S. Digital Therapeutics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
                   5.1 Application Market Share Analysis, 2021 & 2030
                   5.2 U.S. Digital Therapeutics Market, By Application, 2018 To 2030
                   5.3 Diabetes
                       5.3.1 Diabetes Market, 2018 - 2030 (USD Million)
                   5.4 Obesity
                       5.4.1 Obesity Market, 2018 - 2030 (USD Million)
                   5.5 CVD
                       5.5.1 CVD Market, 2018 - 2030 (USD Million)
                   5.6 Respiratory Diseases
                       5.6.1 Respiratory Diseases Market, 2018 - 2030 (USD Million)
                   5.7 Smoking Cessation
                       5.7.1 Smoking Cessation Market, 2018 - 2030 (USD Million)
                   5.8 CNS Disease
                       5.8.1 CNS Disease Market, 2018 - 2030 (USD Million)
                   5.9 Others
                       5.9.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Digital Therapeutics Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
                   6.1 End-Use Market Share Analysis, 2021 & 2030
                   6.2 U.S. Digital Therapeutics Market, By End Use, 2018 To 2030
                   6.3 Patients
                       6.3.1 Patients Market, 2018 - 2030 (USD Million)
                   6.4 Providers
                       6.4.1 Providers Market, 2018 - 2030 (USD Million)
                   6.5 Payers
                       6.5.1 Payers Market, 2018 - 2030 (USD Million)
                   6.6 Employers
                       6.6.1 Employers Market, 2018 - 2030 (USD Million)
                   6.6 Others
                       6.6.1 Others Market, 2018 - 2030 (USD Million)
Chapter 7. U.S. Digital Therapeutics Market - Competitive Analysis
                   7.1 Market Participant Categorization
                       7.1.1. Company Market Position Analysis
                       7.1.2. Synergy Analysis: Major Deals & Strategic Alliances
                       7.1.3. Market Leaders & Innovators
                   7.2. List Of Key Companies
Chapter 8. U.S. Digital Therapeutics Market - Company Profiles
                   8.1 Omada Health Inc.
                       8.1.1 Company Overview
                       8.1.2 Financial Performance
                       8.1.3 End-Use Benchmarking
                       8.1.4 Strategic Initiatives
                   8.2 Teladoc Health, Inc.
                       8.2.1 Company Overview
                       8.2.2 Financial Performance
                       8.2.3 End-Use Benchmarking
                       8.2.4 Strategic Initiatives
                   8.3 2morrow Inc.
                       8.3.1 Company Overview
                       8.3.2 Financial Performance
                       8.3.3 End-Use Benchmarking
                       8.3.4 Strategic Initiatives
                   8.4 Propeller Health (Resmed)
                       8.4.1 Company Overview
                       8.4.2 Financial Performance
                       8.4.3 End-Use Benchmarking
                       8.4.4 Strategic Initiatives
                   8.5 Fitbit Health Solutions
                       8.5.1 Company Overview
                       8.5.2 Financial Performance
                       8.5.3 End-Use Benchmarking
                       8.5.4 Strategic Initiatives
                   8.6 Canary Health
                       8.6.1 Company Overview
                       8.6.2 Financial Performance
                       8.6.3 End-Use Benchmarking
                       8.6.4 Strategic Initiatives
                   8.7 Welldoc, Inc.
                       8.7.1 Company Overview
                       8.7.2 Financial Performance
                       8.7.3 End-Use Benchmarking
                       8.7.4 Strategic Initiatives
                   8.8 Noom, Inc.
                       8.8.1 Company Overview
                       8.8.2 Financial Performance
                       8.8.3 End-Use Benchmarking
                       8.8.4 Strategic Initiatives
                   8.9 Pear Therapeutics, Inc.
                       8.9.1 Company Overview
                       8.9.2 Financial Performance
                       8.9.3 End-Use Benchmarking
                       8.9.4 Strategic Initiatives
                   8.10 Click Therapeutics, Inc.
                       8.10.1 Company Overview
                       8.10.2 Financial Performance
                       8.10.3 End-Use Benchmarking
                       8.10.4 Strategic Initiatives
                   8.11 Akili Interactive Labs, Inc.
                       8.11.1 Company Overview
                       8.11.2 Financial Performance
                       8.11.3 End-Use Benchmarking
                       8.11.4 Strategic Initiatives
                   8.12 Better Therapeutics, Inc
                       8.12.1 Company Overview
                       8.12.2 Financial Performance
                       8.12.3 End-Use Benchmarking
                       8.12.4 Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of Key companies
Table 3 U.S. Digital Therapeutics market, by End-Use, 2018 - 2030 (USD Million)
Table 4 U.S. Digital Therapeutics market, 2018 - 2030 (USD Million)
Table 5 U.S. Digital Therapeutics market, by Application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity workflow analysis
Fig. 9 U.S. Digital Therapeutics market snapshot, 2022 (USD Million)
Fig. 10 U.S. Digital Therapeutics market segmentation and scope
Fig. 11 Parent market outlook
Fig. 12 Ancillary market outlook
Fig. 13 Penetration & growth prospect mapping, 2022
Fig. 14 U.S. Digital Therapeutics market dynamics analysis
Fig. 15 U.S. Digital Therapeutics market driver analysis
Fig. 16 U.S. Digital Therapeutics market restraint analysis
Fig. 17 COVID-19 disease prevalence
Fig. 18 U.S. Digital Therapeutics market: End-Use movement analysis, 2022 & 2030
Fig. 19 U.S. Digital Therapeutics market End-Use outlook: Key takeaways
Fig. 20 Patients market, 2018 - 2030 (USD Million)
Fig. 21 Providers market, 2018 - 2030 (USD Million)
Fig. 22 Payers market, 2018 - 2030 (USD Million)
Fig. 23 Employers market, 2018 - 2030 (USD Million)
Fig. 24 Others market, 2018 - 2030 (USD Million)
Fig. 25 U.S. Digital Therapeutics market: Application movement analysis, 2022 & 2030
Fig. 26 U.S. Digital Therapeutics market Application outlook: Key takeaways
Fig. 27 Diabetes market, 2018 - 2030 (USD Million)
Fig. 28 Obesity market, 2018 - 2030 (USD Million)
Fig. 29 CVD market, 2018 - 2030 (USD Million)
Fig. 30 Respiratory Diseases market, 2018 - 2030 (USD Million)
Fig. 31 Smoking Cessation market, 2018 - 2030 (USD Million)
Fig. 32 CNS Disease market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 Market participant categorization
Fig. 35 Company market position analysis